Results 1 to 4 of about 4 (4)
Increasing transparency in indirect treatment comparisons: is selecting effect modifiers the missing part of the puzzle? A review of methodological approaches and critical considerations. [PDF]
Freitag A, Gurskyte L, Sarri G.
europepmc +1 more source
Patient characteristics as effect modifiers for psoriasis biologic treatment response: an assessment using network meta-analysis subgroups. [PDF]
Wade R, Sharif-Hurst S, Dias S.
europepmc +1 more source
Increased H-Bond Stability Relates to Altered ε-Cleavage Efficiency and Aβ Levels in the I45T Familial Alzheimer's Disease Mutant of APP. [PDF]
Götz A +7 more
europepmc +1 more source
Dissecting conformational changes in APP's transmembrane domain linked to ε-efficiency in familial Alzheimer's disease. [PDF]
Götz A, Scharnagl C.
europepmc +1 more source

